These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3931496)

  • 1. [Animal experiment studies on hemodynamics following partial and total blood exchange with a pyridoxalated polyhemoglobin solution].
    Hobbhahn J; Jesch F; Conzen P; Brendel W; Peter K
    Anaesthesist; 1985 Aug; 34(8):396-401. PubMed ID: 3931496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs.
    Hobbhahn J; Vogel H; Kothe N; Brendel W; Peter K; Jesch F
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):537-43. PubMed ID: 4036540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiologic effects of oxygen transport by hemoglobin solutions.
    Moores WY; White FC; Bloor C; Greenburg AG; Mack R; Willford DC
    Prog Clin Biol Res; 1983; 122():89-99. PubMed ID: 6878384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects after partial exchange transfusion with pyridoxylated polyhemoglobin in chimpanzees.
    Lenz G; Junger H; van den Ende R; Brotman B; Prince AM
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):709-18. PubMed ID: 1810405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of pyridoxalated-polymerized hemoglobin solution.
    Friedman HI; De Venuto F; Schwartz BD; Nemeth TJ
    Surg Gynecol Obstet; 1984 Nov; 159(5):429-35. PubMed ID: 6495140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood exchange with pyridoxalated and polymerized hemoglobin solution.
    DeVenuto F; Zegna A
    Surg Gynecol Obstet; 1982 Sep; 155(3):342-6. PubMed ID: 7112363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial blood: current status of hemoglobin solutions.
    Gould SA; Sehgal LR; Sehgal HL; Moss GS
    Crit Care Clin; 1992 Apr; 8(2):293-309. PubMed ID: 1568141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch.
    Lipfert B; Standl T; Düllmann J; Helmchen U; Schulte am Esch J; Lorke DE
    Lab Invest; 1999 May; 79(5):573-82. PubMed ID: 10334568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.
    Sehgal LR; Gould SA; Rosen AL; Sehgal HL; Moss GS
    Surgery; 1984 Apr; 95(4):433-8. PubMed ID: 6710339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modified hemoglobin as a blood substitute in a rat model].
    Waschke K; Krieter H; Albrecht DM; van Ackern K; Kuschinsky W
    Anaesthesist; 1993 Feb; 42(2):90-5. PubMed ID: 8470790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen-transporting fluids and oxygen delivery with hemodilution.
    Jesch FH; Peters W; Hobbhahn J; Schoenberg M; Messmer K
    Crit Care Med; 1982 Apr; 10(4):270-4. PubMed ID: 7067477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of polymerized pyridoxylated hemoglobin solution as an O2 carrier.
    Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS
    Ann Surg; 1990 Apr; 211(4):394-8. PubMed ID: 2322034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary effects of halothane in hypovolemic dogs.
    Pascoe PJ; Haskins SC; Ilkiw JE; Patz JD
    Am J Vet Res; 1994 Jan; 55(1):121-6. PubMed ID: 8141484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental assessment of the effectiveness of modified polyhemoglobin in the model of extreme hemodilution].
    Kolonina IR; Litvinenko IuA; Sokolov AV
    Biull Eksp Biol Med; 1991 May; 111(5):503-5. PubMed ID: 1878566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study.
    Driessen B; Jahr JS; Lurie F; Golkaryeh MS; Gunther RA
    Crit Care Med; 2003 Jun; 31(6):1771-9. PubMed ID: 12794419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange-transfusion with pyridoxalated polymerized hemoglobin: effects on liver PO2.
    Wehry M; Penner J; Campbell F; Mullins R; Rink R
    Circ Shock; 1987; 23(4):249-61. PubMed ID: 3690818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of epidurally administered morphine and a xylazine-morphine combination in isoflurane-anesthetized dogs.
    Keegan RD; Greene SA; Weil AB
    Am J Vet Res; 1995 Apr; 56(4):496-500. PubMed ID: 7785829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic consequences of halothane anesthesia during chronic anemia.
    Barrera M; Miletich DJ; Albrecht RF; Hoffman WE
    Anesthesiology; 1984 Jul; 61(1):36-42. PubMed ID: 6430129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.